Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3710)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 16, 2022 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He MY, Yan FF, Cen KL, Shen P. Long survival after immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma: A case report and review of literature. World J Clin Cases 2022; 10(32): 11889-11897 [PMID: 36405269 DOI: 10.12998/wjcc.v10.i32.11889] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v10/i32/11889.htm |
| Number | Citing Articles |
| 1 |
Pedro Luiz Serrano Uson Junior, Tanios Bekaii-Saab. Moving Beyond Single-Agent Checkpoint Inhibition in Biliary Tract Cancers: What is the Next Frontier?. Immunotherapy 2023; 15(7): 531 doi: 10.2217/imt-2022-0201
|
| 2 |
Paola Mattiolo, Mario De Bellis, Andrea Mafficini, Matteo Fassan, Michele Bevere, Calogero Ciulla, Samantha Bersani, Rita T. Lawlor, Michele Milella, Aldo Scarpa, Claudio Luchini, Andrea Ruzzenente. Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature. Journal of Gastrointestinal Cancer 2024; 55(4): 1634 doi: 10.1007/s12029-024-01113-8
|
| 3 |
Fei Chen, Jian Sheng, Xiaoping Li, Zhaofeng Gao, Siqi Zhao, Lingyu Hu, Minjie Chen, Jianguo Fei, Zhengwei Song. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma. Biomedicine & Pharmacotherapy 2024; 175: 116659 doi: 10.1016/j.biopha.2024.116659
|
| 4 |
Mateusz Gregorczyk, Eileen E. Parkes. Targeting mitotic regulators in cancer as a strategy to enhance immune recognition. DNA Repair 2023; 132: 103583 doi: 10.1016/j.dnarep.2023.103583
|